Finally, also TRPML1 might have a potential role as a negative prognostic marker for GBM patients (Morelli et al., 2019) since TRPML1 mRNA down-regulation or loss strongly correlates with reduced overall survival in GBM patients. This evidence concerns the gene MCOLN1 and glioblastoma.